Results 31 to 40 of about 209,971 (329)

CD20 Positive T Cell Lymphoma Involvement of Skin [PDF]

, 2011
CD20 positive T cell lymphoma is a rare condition that is associated with the coexpressions of CD20 and T cell markers, such as, CD3, CD5, or UCHL-1. Positivity for CD20 in this tumor represents an aberrant immunophenotype, but the presence of monoclonal
Balmer, Balmer, Buckner, Cerny, Gill, Hamilton-Dutoit, Jin Woo Hong, Ki Ho Kim, Ki Hoon Song, Ki Yeol Lee, Magro, Medeiros, Mohrmann, Murayama, Norton, Oshima, Quintanilla-Martinez, Rahemtullah, Sen, Su Young Jeon, Sun, Tarkowski, Venizelos, Warzynski, Xiao, Yao, Yokose, Young Hun Kim   +27 more
core   +2 more sources

Peripheral T cell lymphoma in Asia [PDF]

International Journal of Hematology, 2014
Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of mature T- and NK-cell neoplasms, the incidence of which is higher in Asian countries than in Western countries. Although its etiology is mainly unknown, several risk factors (such as genetic factors, abnormal immunity, environmental factors, and infectious causes) have been proposed.
Young Hyeh Ko, Sanghui Park
openaire   +3 more sources

Updates in the Treatment of Peripheral T-Cell Lymphomas

Journal of Experimental Pharmacology, 2021
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of rare hematologic malignancies accounting for less than 10% of non-Hodgkin lymphomas. The 2016 classification of World Health Organization recognized 29 different entities of PTCLs. These subgroups are characterized by different molecular and genetic patterns.
Vincent Ribrag, Khalil Saleh, Jean-Marie Michot   +2 more
openaire   +6 more sources

A case of primary peripheral T-cell type non-Hodgkin lymphoma originating in the iris: Clinico-pathological findings [PDF]

, 2010
Background. The ocular adnexal region is the primary localization of extranodal lymphoma in 5% to 15% of all Non-Hodgkin lymphoma. Intraocular lymphoma of T-cell origin is extremely rare and such sites of infiltration have been rarely observed in ...
Jaković Ljubomir, Kovačević Dragana, Latković Zoran, Mihaljević Biljana, Peruničić-Jovanović Maja, Rašić Dejan, Sretenović Aleksandra   +6 more
core   +1 more source

Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707

Haematologica, 2017
The standard CHOP therapy for peripheral T-cell lymphoma has resulted in unsatisfactory outcomes and it is still not clear what is the optimal front-line therapy.
Yoshinobu Maeda, Hisakazu Nishimori, Isao Yoshida, Yasushi Hiramatsu, Masatoshi Uno, Yasufumi Masaki, Kazutaka Sunami, Taro Masunari, Yuichiro Nawa, Hiromichi Yamane, Hiroshi Gomyo, Tsutomu Takahashi, Tomofumi Yano, Keitaro Matsuo, Koichi Ohshima, Shigeo Nakamura, Tadashi Yoshino, Mitsune Tanimoto   +17 more
doaj   +1 more source

Multiple osteolytic primary peripheral T-cell bone lymphoma: the first case report

Journal of International Medical Research, 2021
Peripheral T-cell lymphoma accounts for about 10% of all cases of non-Hodgkin’s lymphoma. However, less than 5% of patients with non-Hodgkin’s lymphoma present with hypercalcaemia as the initial symptom, and less than 1% present with primary bone lesions.
Chen Li, Weiguo Wang, Lingyun Xu, Dingyun Zheng, Miao Zhang, Qin Zhang, Xiaoqian Wu, Yue Yao, Wenyue Huang, Xue Li, Peipei Ying, Xiuxiu Wang, Liu Shang, Yuhu Feng   +13 more
doaj   +1 more source

Burrowing through the heterogeneity: Review of mouse models of PTCL-NOS [PDF]

, 2016
Currently, there are 19 different peripheral T-cell lymphoma (PTCL) entities recognized by the World Health Organization; however, ~70% of PTCL diagnoses fall within one of three subtypes [i.e., peripheral T-cell lymphoma not otherwise specified (PTCL ...
Agostinelli, Basakran, Beachy, Boman, Bonnet, Bug, Canela, Chan, Chu, Cook, Cornal, Costello, Cotta, Dick, Dierks, Dutta, Feldman, Felsher, Friend, Ishiguro, Kuppers, Morrow, Munoz, Nagel, Orchansky, Ortega, Park, Pattengale, Pechloff, Roberts, Rohr, Rudiger, Savage, Sentman, Soulier, Teramoto, Toya, Wang, Wang, Warner, Yan   +40 more
core   +3 more sources

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation

Haematologica, 2010
Background T follicular helper (TFH) cells reside in the light zone of germinal centers and are considered the cell of origin of angioimmunoblastic T-cell lymphoma.
Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, Andreas Chott, Yasodha Natkunam, Manuel Rodriguez-Justo, Anne Plonquet, Socorro M. Rodriguez-Pinilla, Wolfram Klapper, Martin-L. Hansmann, Stefano A. Pileri, Peter G. Isaacson, Harald Stein, Miguel A. Piris, David Y. Mason, Philippe Gaulard   +15 more
doaj   +1 more source

Lymphoma of the Uvula: Clinical, Morphological, Histopathological, and Genetic Characterization. A Nationwide Danish Study From 1980 to 2019

Frontiers in Surgery, 2021
Background: In the head and neck region the uvula is a rare site for extranodal lymphomas to develop. In this national study, we present six cases and provide an overview of the current literature, characterizing the clinical and histopathological ...
Lars Iversen, Lars Iversen, Patrick Rene Gerhard Eriksen, Simon Andreasen, Simon Andreasen, Erik Clasen-Linde, Preben Homøe, Irene Wessel, Christian von Buchwald, Steffen Heegaard, Steffen Heegaard   +10 more
doaj   +1 more source

Prognostic Markers in Peripheral T-Cell Lymphoma [PDF]

Current Hematologic Malignancy Reports, 2010
Based on their own experience and knowledge of the literature, the authors review the pathobiological characteristics of peripheral T-cell lymphomas (PTCLs), focusing on the available prognostic indicators. The International Prognostic Index (IPI), which is based on age, performance status, lactate dehydrogenase [LDH], stage, and extranodal involvement,
PICCALUGA, PIER PAOLO, AGOSTINELLI, CLAUDIO, GAZZOLA, ANNA, Mannu C, BACCI, FRANCESCO, SABATTINI, ELENA, PILERI, STEFANO   +6 more
openaire   +3 more sources